ANCA-associated vasculitis trials in Poland

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

  Where

  Chęciny, Gdansk, Lodz

  Age

  6 years and over

  People

  230 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07444567
• Phase 3Taking people
  A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

  Where

  Kielce, Warsaw

  Age

  6 years to 17 years

  People

  14 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06512883 · EU 2023-508533-14-00
• Phase 4Taking people
  A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

  Where

  Lodz, Warsaw

  Age

  18 years to 100 years

  People

  300 worldwide

  Run by

  Amgen

  See details and how to joinNCT06072482
• Phase 3Taking people
  ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment

  Where

  Checiny, Gdansk, Lodz

  People

  94 worldwide

  Run by

  AstraZeneca AB

  See details and how to join2025-523307-29-00 · EU 2025-523307-29-00
• No phaseTaking people
  Ocular Manifestations of Granulomatosis With Polyangiitis.

  Where

  Warsaw

  Age

  18 years and over

  People

  70

  Run by

  Military Institute od Medicine National Research Institute

  See details and how to joinNCT07664709